ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed
Ming Yu
Matched on ORCID iD 0000-0002-1156-005X; OpenAlex author ID A5016950696. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 6
- Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression. Last author DOI 10.3892/ol.2019.11157↗
- Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2016.05.016↗
- Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2014.08.001↗
- The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. Co-author DOI 10.1002/jcb.24608↗
- Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells. Co-author DOI 10.3892/or.2012.2085↗
- Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. Co-author DOI 10.1371/journal.pone.0043399↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tiansuo Zhao · 4 shared papers, 2012–2020 · strength 0.27
- Paper Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression. DOI 10.3892/ol.2019.11157↗
- Paper Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells. DOI 10.1016/j.canlet.2014.08.001↗
- Paper The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. DOI 10.1002/jcb.24608↗
- Fanjie Jin · 1 shared paper, 2020 · strength 0.16
- Jihui Hao · 4 shared papers, 2012–2016 · strength 0.16
- Paper Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2016.05.016↗
- Paper Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells. DOI 10.1016/j.canlet.2014.08.001↗
- Paper The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. DOI 10.1002/jcb.24608↗
- Xiuchao Wang · 3 shared papers, 2012–2016 · strength 0.12
- Paper Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2016.05.016↗
- Paper The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. DOI 10.1002/jcb.24608↗
- Paper Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly … DOI 10.1371/journal.pone.0043399↗
- He Ren · 2 shared papers, 2012–2016 · strength 0.08
- He Ren · 2 shared papers, 2013–2014 · strength 0.08
- Song Gao · 2 shared papers, 2012–2013 · strength 0.07
- Shengyu Yang · 1 shared paper, 2016 · strength 0.05
- Mingxiao Lang · 1 shared paper, 2016 · strength 0.05
- Chongbiao Huang · 1 shared paper, 2016 · strength 0.05
- Yanhui Yang · 1 shared paper, 2016 · strength 0.05
- Tongjun Liu · 1 shared paper, 2013 · strength 0.04
- Huijie Xiao · 1 shared paper, 2013 · strength 0.04
- Dapeng Zhang · 1 shared paper, 2013 · strength 0.04
- Feng Wang · 1 shared paper, 2013 · strength 0.04
- Huan Zhang · 1 shared paper, 2014 · strength 0.04
- Jing Chen · 1 shared paper, 2014 · strength 0.04
- Junwei Sun · 1 shared paper, 2013 · strength 0.04
- Feng Wang · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.